CADUS PHARMACEUTICALS
Similar Organizations
Boston Pharmaceuticals
Boston Pharmaceuticals Provides Healthcare Services.
pharmaceutical companies
pharmaceutical companies is a Biotechnology company.
More informations about "Cadus Pharmaceuticals"
Cadus Sells Drug Discovery Program, Assets to OSI Pharmaceuticals
Aug 6, 1999 Cadus Pharmaceutical Corp. develops novel drug discovery technologies that exploit the similarities between the yeast and human genomes and utilize yeast cells as the …See details»
The Top 25 Biotech CEOs of 2020
FOCUS ON CADUS PHARMACEUTICAL - Pharmaceutical industry …
Apr 4, 1993 Cadus Pharmaceutical, a privately-owned biopharmaceutical company based in Manhattan, USA, has licensed technology based on cellular signal transduction pathways from …See details»
Cadus Pharmaceutical Corporation - life-sciences-usa.com
BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) France Biotech; Life Science Washington; Virginia Biotechnology Organisation (VirginiaBio) ...See details»
The Standard: Cadus Pharmaceutical Corporation
Cadus Pharmaceutical hopes to make some dough from yeast. The firm developed drug discovery technologies based on the use of genetically engineered yeast cells. Its researchers …See details»
Cadus Pharmaceuticals - Drug pipelines, Patents, Clinical trials
Last update 11 Jul 2024. Cadus Pharmaceuticals. Private CompanySee details»
Cadus Corp. Fundamental Company Report Including Financial, …
The company was founded in 1992. It was formerly known as Cadus Pharmaceutical Corporation and changed its name to Cadus Corporation in 2003. The above Company Fundamental …See details»
Cadus Pharmaceutical Corporation in Tarrytown NY - Company …
Nov 29, 1995 Cadus Pharmaceutical Corporation filed as a Foreign Business Corporation in the State of New York on Wednesday, November 29, 1995 and is approximately thirty years old, …See details»
New BIO Chair Vows Crackdown on Biopharma’s “Bad …
Jun 7, 2019 Cadus was assessed $18 million in damages—a judgment reversed by the U.S. Court of Appeals for the Federal Circuit in 2000, after Cadus sold its drug discovery assets to OSI Pharmaceuticals and ...See details»
Cadus Pharmaceutical - Pink Sheet
NYC-based Cadus is researching signal transduction pathways as targets for potential inflammatory, cardiovascular and neuro-psychiatric therapies. ImClone Systems spinoff raises …See details»
Cadus 2025 Company Profile: Valuation, Investors, Acquisition
Cadus Pharmaceutical, Cadus Pharmaceutical Corp. Ownership Status. Acquired/Merged. Financing Status. Corporate Backed or Acquired. Corporate Office. 767 Fifth Avenue; Suite …See details»
Cadus To Get $10M In Expansion Of Bristol-Myers Drug Pact
Jan 9, 1997 SAN FRANCISCO — Bristol-Myers Squibb agreed to pay Cadus Pharmaceuticals Corp. $10 million over the next two years to extend and expand its drug discovery …See details»
Our Team - Evrys Bio
Dana co-founded Cadus Pharmaceutical Corp and Novalon Pharmaceutical Corp. where he negotiated the company’s $107 million merger with Karo Bio AB. ... He previously served as …See details»
Charles Woler - SPRIM
Charles Woler has 20 years of pharmaceutical experience in different R&D, Marketing & Sales, and General Management positions, including: CEO Roche France (Pharma, Diagnostic, Fine …See details»
Cadus Pharmaceuticals - Crunchbase
Cadus Pharmaceuticals is a biotechnology company. Similar Companies. Edit Similar Companies SectionSee details»
Cadus Licenses GPCRs Technologies to OSI - Drug Discovery Online
Feb 24, 2000 Cadus Pharmaceutical Corp. develops drugs to treat diseases caused by signal malfunctions between and within human cells. For more information: Charles Woler, President …See details»
Patents Assigned to Cadus Pharmaceutical Corporation
Sep 13, 2001 Assignee: Cadus Pharmaceutical Corporation Inventors: Dana M. Fowlkes, Jim Broach, John Manfredi, Christine Klein, Andrew J. Murphy, Jeremy Paul, Joshua Trueheart …See details»
Major changes are planned at CADUS for 2023 - cadus.org
The year 2022 was full of ups and downs - in the world and in our company. The events have changed both us personally and CADUS. We would like to report on this intensive period and …See details»
Zydus to enter global biologics CDMO business: Plans to
21 hours ago The acquisition will establish Zydus' presence in fast growing global biologics CDMO space. Acquired capabilities include cutting-edge biologics development and …See details»
Recommended Stories - Yahoo Finance Canada
1 day ago Zydus' CDMO business will operate as an independent entity and will house the acquired manufacturing capabilities. The facilities come with an experienced professional team …See details»